KALA KALA BIO, Inc.


$ 1.46 $ -0.05 (-3.31 %)    

Wednesday, 15-Oct-2025 09:59:12 EDT
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
$ 1.48
$ 1.45 x 1,200
$ 1.47 x 100
$ 1.44 - $ 1.50
$ 1.10 - $ 20.60
418,571
na
10.6M
$ 0.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 on-sep-29-kala-bio-receives-notice-of-event-of-default-from-oxford-finance-total-obligations-declared-payable-is-291m

-SEC Filing

 crude-oil-falls-sharply-carnival-posts-upbeat-earnings

U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Monday. The Dow traded do...

Core News & Articles

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

 why-is-eye-disease-focused-kala-bio-stock-plunging-on-monday

Kala Bio Inc. (NASDAQ: KALA) stock is down on Monday after the company halted development of its experimental treatment for a s...

 kala-bio-shares-resume-trade
KALA BIO Shares Resume Trade
09/29/2025 15:03:17

 nasdaq-jumps-150-points-us-pending-home-sales-rise

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. Following the market ...

 hc-wainwright--co-maintains-buy-on-kala-bio-raises-price-target-to-35

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio (NASDAQ:KALA) with a Buy and raises the price target from $12 to ...

 oppenheimer-maintains-outperform-on-kala-bio-raises-price-target-to-33

Oppenheimer analyst Andreas Argyrides maintains Kala Bio (NASDAQ:KALA) with a Outperform and raises the price target from $1...

 mizuho-initiates-coverage-on-kala-bio-with-outperform-rating-announces-price-target-of-30

Mizuho analyst Graig Suvannavejh initiates coverage on Kala Bio (NASDAQ:KALA) with a Outperform rating and announces Price T...

 5-healthcare-stocks-on-fire-this-week

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech &...

 kala-bio-q2-eps-171-beats-182-estimate

Kala Bio (NASDAQ:KALA) reported quarterly losses of $(1.71) per share which beat the analyst consensus estimate of $(1.82) by 6...

 ladenburg-thalmann-initiates-coverage-on-kala-bio-with-buy-rating-announces-price-target-of-12

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Kala Bio (NASDAQ:KALA) with a Buy rating and announces Price...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION